Skip to content
Home India Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals Notifications Jan Aushadhi Kendras in Uttar Pradesh... (Official PDF)
Date: 31st July 2026 Category: Press Release Jurisdiction: India, Central Government

Jan Aushadhi Kendras in Uttar Pradesh - 31st July 2026 - Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals - Gazette Notification PDF

Issued by Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals

Read or download the official PDF of this gazette notification issued by the Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals on 31st July 2026. Classified under Press Release.

Executive Summary & Key Takeaways

Executive Summary This report outlines the status and enhancement measures for Jan Aushadhi Kendras (JAKs) in Uttar Pradesh as of June 30, 2026, under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana. It details the Pharmaceuticals and Medical Devices Bureau of India’s (PMBI) strategies for monitoring, supply chain optimization, and national awareness, including the annual Jan Aushadhi Week in March. Key focus areas include reviving low-performing units and implementing IT-enabled supply chain systems to ensure the availability of affordable generic medicines.

Key Points / Main Content

Operational Status and Monitoring

  • As of June 30, 2026, Uttar Pradesh has 4,226 operational JAKs, with 17 located in the Hathras district (two of which are currently non-operational).
  • The PMBI utilizes an IT-enabled system to continuously monitor sales, stock positions, and overall functioning.
  • State Level Marketing Officers identify low-performing units to provide handholding, workshops, and peer-learning opportunities.

Awareness and Public Outreach

  • Multi-platform campaigns are conducted via print, television, radio, social media, and outdoor media in coordination with agencies like PIB and MyGov.
  • Direct engagement is pursued through WhatsApp chatbots and outbound calls to inform citizens about quality and cost savings.
  • "Jan Aushadhi Week" is held annually during the first week of March, featuring health camps, rallies, and seminars.
  • Rural outreach includes "nukkad-natak" (street plays) and publicity in local dialects at Common Service Centres (CSCs).

Supply Chain and Inventory Management

  • Since September 2024, JAK owners receive monthly incentives for maintaining stocks of 200 commonly used medicines (100 top-selling and 100 fast-selling).
  • The supply chain infrastructure consists of five warehouses and a network of 42 distributors nationwide, linked by an end-to-end IT system.
  • PMBI regularly monitors 400 fast-moving products and has digitized the demand estimation process to improve procurement efficiency.

Impact Analysis

Jan Aushadhi Kendra (JAK) Owners Impact Owners of low-performing stores receive specialized training and support to revive sales. Additionally, they are eligible for financial incentives based on inventory maintenance. Action Required Owners must maintain adequate stocks of the 200 designated medicines to qualify for incentives and participate in PMBI-organized workshops if sales targets are not met.

Citizens and Healthcare Professionals Impact Increased awareness of the quality and affordability of generic medicines helps reduce healthcare costs and dispel myths regarding generic drugs. Action Required Citizens are encouraged to use digital tools like the WhatsApp chatbot to find nearby centers and participate in educational programs held during Jan Aushadhi Week.

Pharmaceuticals and Medical Devices Bureau of India (PMBI) Impact As the implementing agency, the PMBI is responsible for the digital transformation of the supply chain and the continuous evaluation of the scheme’s effectiveness. Action Required The Bureau must continue to monitor the 400 fast-moving products and refine digitized procurement estimation methods to prevent stockouts.

Key Entities Referenced

Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP): A national scheme aimed at providing quality generic medicines at affordable prices to all through dedicated retail outlets. Pharmaceuticals and Medical Devices Bureau of India (PMBI): The nodal implementing agency under the Department of Pharmaceuticals responsible for monitoring, managing, and promoting the Jan Aushadhi Kendras. Jan Aushadhi Kendras (JAKs): Specialized retail outlets established under the PMBJP to dispense generic medicines and provide healthcare products to the public. Uttar Pradesh: The primary state of focus for this report, specifically detailing the operation and status of 4,226 Jan Aushadhi Kendras including those in the Hathras district.
Official Gazette PDF Record Download Official PDF (Jan Aushadhi Kendras in Uttar...) →

Official Gazette Notification PDF Viewer

See Full Document Text & PDF Transcript
Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals Jan Aushadhi Kendras in Uttar Pradesh प्रव तथ: 31 JUL 2026 4:35PM by PIB Delhi Under Pradhan Mantri Bhartiya Janaushadhi Pariyojana, a total of 4,226 Jan Aushadhi Kendras (JAKs) have been opened in the State of Uttar Pradesh as on 30.06.2026, of which 17 JAKs have been opened in the Hathras district. In the Hathras district of Uttar Pradesh, 02 Jan Aushadhi Kendras have become non-operational till 30.06.2026. The Pharmaceuticals and Medical Devices Bureau of India (PMBI), the implementing agency of the scheme continuously monitors the functioning of Jan Aushadhi Kendras through an IT-enabled monitoring system, regular review of sales and stock positions. Further, the State Level Marketing Officer of PMBI, establishes contact with JAKs whose sales are low with a view to help revive sales. PMBI handholds JAKs and organises workshops, peer learning from successful JAK owners and meeting with doctors from the local area for JAKs performing less well. The Government has taken several measures to ensure the effective functioning of Jan Aushadhi Kendras creating awareness regarding generic medicines and ensuring regular supply of medicines. Details are as under: - In order to promote acceptability and to increase sale of medicines supplied through JAKs, targeted awareness campaigns about the benefits of Janaushadhi medicines are conducted on a regular basis: i. Awareness campaigns: Pharmaceuticals and Medical Devices Bureau of India (PMBI), conducts awareness campaigns in coordination with bodies and platforms such as the Central Bureau of Communication, PIB, MyGov and MY Bharat, in various modes such as print, television, radio, social media platforms, outdoor hoardings, community engagement, etc. ii. Interactive messages/calls: Outreach and citizen engagement are also pursued through WhatsApp chatbot and outbound calls to inform citizens regarding the quality of Janaushadhi products and the large savings that accrue from purchase of the same from nearest JAK. iii. Jan Aushadhi Week: Jan Aushadhi Week is celebrated every year in the first week of March during which special campaigns such as public rallies, health camps, seminars in pharmacy colleges, children engagement programmes, etc. are conducted across the nation to educate citizens, healthcare professionals and other stakeholders about the benefits of Janaushadhi generic medicines. iv. Messages from eminent persons: Audio/video messages from well-known persons such as public representatives and eminent doctors are disseminated on social media platforms to highlight the benefits of Janaushadhi medicines and dispel myths associated with respect to their quality.v. Public engagement programme in rural areas: To educate citizens in local languages/dialects, publicity is also done through health camps, nukkad-natak, audio-visual display at Common Service Centres and public engagement workshops in association with local JAKs in rural areas. In order to address any supply gaps and ensure smooth supply and availability of products at JAKs, the following measures are in place: i. Since September 2024, stocking by JAKs of 200 commonly used medicines, consisting of the 100 top-selling medicines in the scheme product basket and 100 fast-selling medicines in the market, has been incentivised, under which JAK owners are eligible for monthly incentive based on the stocks that they maintain for these medicines. ii. An end-to-end information-technology-enabled supply chain system is in place to connect a robust supply chain system consisting of five warehouses and a growing network of distributors across the country, currently numbering 42. iii. In addition, with a view to ensure availability of commonly used products, 400 fast-moving products are monitored regularly by Pharmaceuticals and Medical Devices Bureau of India (PMBI), the scheme implementing agency, and demand for the same is estimated on a continuous basis. Further, steps have been taken to digitise the estimation method to augment the procurement process. This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a written reply in the Lok Sabha today. ***** PC/PM (रलीज़ आईडी: 2292474) आगंतुक पटल : 244 इस वज्ञ को इन भाषाओ ंम पढ़: Urdu , ही

Continue your research